2009
DOI: 10.1002/ajmg.a.33183
|View full text |Cite
|
Sign up to set email alerts
|

Proceedings from the 2009 genetic syndromes of the Ras/MAPK pathway: From bedside to bench and back

Abstract: The RASopathies are a group of genetic syndromes caused by germline mutations in genes that encode components of the Ras/mitogen-activated protein kinase (MAPK) pathway. Some of these syndromes are neurofibromatosis type 1, Noonan syndrome, Costello syndrome, cardio-facio-cutaneous syndrome, LEOPARD syndrome and Legius syndrome. Their common underlying pathogenetic mechanism brings about significant overlap in phenotypic features and includes craniofacial dysmorphology, cardiac, cutaneous, musculoskeletal, GI … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
80
0
1

Year Published

2010
2010
2017
2017

Publication Types

Select...
6
2

Relationship

5
3

Authors

Journals

citations
Cited by 91 publications
(81 citation statements)
references
References 3 publications
0
80
0
1
Order By: Relevance
“…15 Although the severity scoring system described here cannot measure the short-term effects of drug treatment, it is useful in quantifying the differences in severity anticipated with the respective mutations and may thereby guide enrollment criteria. Furthermore, changes in the long-term outcome may be assessed through this severity score.…”
Section: Resultsmentioning
confidence: 99%
“…15 Although the severity scoring system described here cannot measure the short-term effects of drug treatment, it is useful in quantifying the differences in severity anticipated with the respective mutations and may thereby guide enrollment criteria. Furthermore, changes in the long-term outcome may be assessed through this severity score.…”
Section: Resultsmentioning
confidence: 99%
“…In light of the many similar medical issues for individuals with any rasopathy, a clinic model combining patients with these conditions is beneficial as it allows the specialists to become more familiar with these conditions. 50 Two of the rasopathies, NF1 and Noonan syndrome, are relatively common, and most healthcare institutions are familiar with their phenotype and medical issues. Specialists, such as cardiologist caring for Noonan syndrome individuals, can become familiar with the phenotypic presentation and may be more comfortable caring for a patient with Costello syndrome.…”
Section: The Rasopathies Clinic: a Pragmatic Care Modelmentioning
confidence: 99%
“…Costello syndrome (MIM #218040) is a rare multiple anomaly syndrome , and beyond infancy, can be differentiated from phenotypically similar Ras/MAPK pathway syndromes (''RASopathies'') [Rauen et al, 2010], that is, Cardiofaciocutaneous (CFC) syndrome (#115150) and Noonan syndrome (#163950). Other RASopathies which have similar pathogenetic activation of Ras/MAPK, but have little phenotypic overlap include Noonan syndrome with multiple lentigines (formerly known as LEOPARD syndrome) (#151100, #611554), capillary malformationarteriovenous malformation syndrome (#139150), or neurofibromatosis type 1 (#162200) [Quezada and Gripp, 2007;Denayer et al, 2008;Tidyman and Rauen, 2008;Rauen et al, 2010].…”
Section: Introductionmentioning
confidence: 99%
“…Other RASopathies which have similar pathogenetic activation of Ras/MAPK, but have little phenotypic overlap include Noonan syndrome with multiple lentigines (formerly known as LEOPARD syndrome) (#151100, #611554), capillary malformationarteriovenous malformation syndrome (#139150), or neurofibromatosis type 1 (#162200) [Quezada and Gripp, 2007;Denayer et al, 2008;Tidyman and Rauen, 2008;Rauen et al, 2010]. Phenotypic features of Costello syndrome include polyhydramnios, increased birth weight, feeding problems, failure to thrive, short stature, developmental delay, pleasant personality, characteristic facial appearance, soft skin, papillomata, spatulate fingerpads, deep palmar creases, joint and skin laxity, kyphoscoliosis, pectus, and splayed fingers with ulnar deviation.…”
Section: Introductionmentioning
confidence: 99%